Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Experts Debate Prospects Of Third-Party Agency To Oversee Off-Label Communications

This article was originally published in The Gray Sheet

Executive Summary

The Duke-Margolis Center has released a list of policy changes that experts argue could improve how off-label communication is disseminated. Among the proposals is a third-party organization to vet off-label communication and a tiered labeling system.


Related Content

Podcast: McClellan Discusses Off-Label Communication Reform
Proposed Intended-Use Amendments Invite Questions About FDA's Off-Label Intentions
Device Firms Should Not Ignore Pharma Off-Label Suits, Experts Say
Off-Label Promotion Ruling Increases Pressure For FDA Policy Change





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts